Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Partners Innovation Fund joined Syncona to provide $20m for the neurological disease drug developer's series A round, which is sized at up to $77m.

The Parkinson's disease therapy developer completed a series A round featuring QB3-aligned Mission Bay Capital.

SwanBio, based on research at Harvard Medical School, has secured a $20m extension to bring its series A round to $45m so far, with commitments to increase it to $77m.

Novartis DRX was among the investors in a $12.9m for the medical personnel database operator that lifted its overall funding close to $20m.

Satt AxLR-allied Phost'in Therapeutics has secured funding to progress cancer drugs targeting glycosylation and the body's immune system.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Parkinson's disease therapy developer completed a series A round co-led by AbbVie Ventures, which will also take a board seat at the company.

Ru-Net participated in an $11.2m round for fresh produce sourcing platform Bijak, which is in discussions to extend the round further.

SoftBank and Legend Capital have invested $150m in the home-grown bicycle sharing platform that will be added to $850m from parent company Didi Chuxing.